Implications of bleeding and blood transfusion in percutaneous coronary intervention

Area of Science:

• Cardiology
• Interventional Cardiology
• Patient Safety

Background:

• Bleeding complications are a significant clinical concern for patients undergoing percutaneous coronary intervention (PCI).
• Advances in pharmacotherapy and devices have reduced ischemic outcomes, shifting focus to bleeding events.
• Discrepancies in bleeding incidence reporting exist due to varied classification systems and data sources (clinical trials vs. registries).

Purpose of the Study:

• To highlight bleeding complications as a major clinical concern in percutaneous coronary intervention (PCI).
• To address the complexities in determining bleeding incidence and risk factors.
• To explore the association between PCI-related bleeding and adverse outcomes like myocardial infarction, stroke, or death.

Main Methods:

• Review of clinical trials and registry data on bleeding events in PCI patients.
• Analysis of factors influencing reported bleeding incidence.
• Examination of potential associations between bleeding complications and major adverse cardiovascular events.

Main Results:

• Registry data indicate a higher incidence of bleeding in clinical practice compared to clinical trials for PCI patients.
• Multiple bleeding severity classification systems complicate incidence determination.
• A potential association exists between PCI-related bleeding and adverse outcomes such as myocardial infarction, stroke, or death.

Conclusions:

• Reducing bleeding risk during PCI is a critical goal that may enhance patient survival and comfort.
• Strategies like careful vascular access, radial artery access, and modified antithrombotic regimens can mitigate bleeding risks.
• Further research is needed to standardize bleeding event reporting and classification for better patient outcomes.